Zymeworks (ZYME) Earnings Analysis
Zymeworks (ZYME) next reports earnings on 2026-08-06, consensus EPS -0.44833 USD. Last quarter (2026-05-07) it missed with EPS -0.59 USD vs -0.1 USD est (-490%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E -17.06.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ZYME next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.44833 USD |
| Revenue estimate | 0.02B |
ZYME earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.59 USD | -0.1 USD | -490% | Miss |
| 2026-03-02 | -0.55 USD | -0.35 USD | -57.1% | Miss |
| 2025-11-06 | -0.26 USD | -0.3 USD | +13.3% | Beat |
| 2025-03-05 | -0.31 USD | 0.01 USD | -3200% | Miss |
| 2024-10-31 | -0.39 USD | -0.4 USD | +2.5% | Beat |
| 2024-08-01 | -0.49 USD | -0.4175 USD | -17.4% | Miss |
Beat rate: 2/6 (33%) over reported quarters with consensus data.
ZYME valuation and analyst view
| Trailing P/E | -17.06 |
|---|---|
| Trailing EPS | -1.37481 USD |
| Price / book | 10.66 |
| Dividend yield | 0.00% |
| Market cap | 1.73B |
| Analyst consensus | Buy (19 buy / 2 hold / 0 sell) |
| Avg price target | 35.5 USD |
Related research pages
Frequently asked questions
When is Zymeworks (ZYME)'s next earnings date?
Zymeworks is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.44833 USD and revenue estimate of 0.02B.
Did ZYME beat earnings last quarter?
In its 2026-05-07 report, ZYME posted EPS of -0.59 USD versus a -0.1 USD estimate — a miss of 490%.
What is ZYME's earnings track record?
Over the last 6 reported quarters with consensus data, ZYME beat estimates 2 times (33%).
What is ZYME's current P/E ratio and EPS?
ZYME trades at a trailing P/E of -17.06 on trailing EPS of -1.3748141799140206 USD.
What do analysts rate ZYME?
Analyst consensus is "Buy" across 21 ratings (0 strong buy, 19 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 35.5 USD.